TerraGen Diversity, Trega Biosciences Inc. deal

TerraGen will acquire the assets of TRGA's ChromaXome Corp. subsidiary, including technologies for generating and screening libraries of complex organic molecules derived from combinatorial biosynthesis. TerraGen will pay $5 million in cash over 16 months and 600,000 shares of TerraGen preferred stock. ...